Top Healthcare companies in United States by EBIT Margin

This ranking features the top 470 Healthcare companies in United States ranked by EBIT Margin, averaging a EBIT Margin of -7,843.75%, for February 04, 2025.

United States

Healthcare

#	Name	EBIT Margin	Reported Date	Stock Price	Change	Country
1	Inhibrx Biosciences, Inc. 1 INBX	95,369.20%	Sept. 30, 2024	USD 12.72	-6.33%	United States
2	Maravai LifeSciences Holdings, Inc. 2 MRVI	178.05%	Sept. 30, 2024	USD 4.94	0.20%	United States
3	Royalty Pharma plc 3 RPRX	76.05%	Dec. 31, 2023	USD 31.33	-0.79%	United States
4	SIGA Technologies, Inc. 4 SIGA	60.19%	Sept. 30, 2024	USD 5.78	-3.34%	United States
5	United Therapeutics Corporation 5 UTHR	52.28%	Sept. 30, 2024	USD 354.58	0.97%	United States
6	Halozyme Therapeutics, Inc. 6 HALO	51.60%	Sept. 30, 2024	USD 56.28	-0.64%	United States
7	Protagonist Therapeutics, Inc. 7 PTGX	45.78%	Sept. 30, 2024	USD 37.20	-1.59%	United States
8	Lantheus Holdings, Inc. 8 LNTH	39.41%	Sept. 30, 2024	USD 89.54	-3.21%	United States
9	Doximity, Inc. 9 DOCS	39.10%	Sept. 30, 2024	USD 59.10	NA	United States
10	Catalyst Pharmaceuticals, Inc. 10 CPRX	35.70%	Sept. 30, 2024	USD 22.62	0.27%	United States
11	Utah Medical Products, Inc. 11 UTMD	33.70%	Sept. 30, 2024	USD 59.92	-2.14%	United States
12	Semler Scientific, Inc. 12 SMLR	33.43%	Sept. 30, 2024	USD 50.46	-2.89%	United States
13	Collegium Pharmaceutical, Inc. 13 COLL	33.14%	Sept. 30, 2024	USD 31.20	-2.86%	United States
14	Regeneron Pharmaceuticals, Inc. 14 REGN	31.50%	Sept. 30, 2024	USD 666.85	-0.91%	United States
15	ResMed Inc. 15 RMD	31.39%	Dec. 31, 2024	USD 240.55	1.85%	United States
16	IRadimed Corporation 16 IRMD	31.05%	Sept. 30, 2024	USD 59.35	0.24%	United States
17	Amphastar Pharmaceuticals, Inc. 17 AMPH	29.34%	Sept. 30, 2024	USD 33.39	-4.24%	United States
18	Waters Corporation 18 WAT	29.30%	Sept. 28, 2024	USD 411.19	-1.03%	United States
19	Exelixis, Inc. 19 EXEL	29.22%	Sept. 27, 2024	USD 32.88	-0.81%	United States
20	Roper Technologies, Inc. 20 ROP	28.91%	Dec. 31, 2024	USD 577.04	0.24%	United States
21	AbbVie Inc. 21 ABBV	28.60%	Sept. 30, 2024	USD 190.14	3.39%	United States
22	Ironwood Pharmaceuticals, Inc. 22 IRWD	27.51%	Sept. 30, 2024	USD 2.10	-10.47%	United States
23	Eli Lilly and Company 23 LLY	26.54%	Sept. 30, 2024	USD 810.43	-0.08%	United States
24	Edwards Lifesciences Corporation 24 EW	26.45%	Sept. 30, 2024	USD 71.38	-1.48%	United States
25	Entrada Therapeutics, Inc. 25 TRDA	26.43%	Sept. 30, 2024	USD 13.33	-0.82%	United States
26	Harmony Biosciences Holdings, Inc. 26 HRMY	26.41%	Sept. 30, 2024	USD 38.70	-0.18%	United States
27	Neurocrine Biosciences, Inc. 27 NBIX	26.23%	Sept. 30, 2024	USD 150.10	-1.13%	United States
28	Intuitive Surgical, Inc. 28 ISRG	26.11%	Sept. 30, 2024	USD 578.55	1.17%	United States
29	National Research Corporation 29 NRC	25.92%	Sept. 30, 2024	USD 16.36	-1.86%	United States
30	Johnson & Johnson 30 JNJ	25.34%	Sept. 29, 2024	USD 151.87	-0.18%	United States
31	Hologic, Inc. 31 HOLX	24.50%	Sept. 28, 2024	USD 71.72	-0.58%	United States
32	Elevance Health Inc. 32 ELV	24.19%	Dec. 31, 2024	USD 405.10	2.38%	United States
33	Biogen Inc. 33 BIIB	24.09%	Sept. 30, 2024	USD 142.34	-1.10%	United States
34	LeMaitre Vascular, Inc. 34 LMAT	23.81%	Sept. 30, 2024	USD 95.43	-1.55%	United States
35	Krystal Biotech, Inc. 35 KRYS	23.75%	Sept. 30, 2024	USD 159.03	-0.44%	United States
36	Agilent Technologies, Inc. 36 A	23.73%	Oct. 31, 2024	USD 148.63	-1.91%	United States
37	Merck & Co., Inc. 37 MRK	23.68%	Sept. 30, 2024	USD 99.79	0.98%	United States
38	ADMA Biologics, Inc. 38 ADMA	23.58%	Sept. 30, 2024	USD 16.47	1.98%	United States
39	Amgen Inc. 39 AMGN	23.05%	Sept. 30, 2024	USD 288.87	1.21%	United States
40	Corcept Therapeutics Incorporated 40 CORT	22.69%	Sept. 30, 2024	USD 66.55	-0.55%	United States
41	Organon & Co. 41 OGN	22.27%	Sept. 30, 2024	USD 14.91	-4.18%	United States
42	European Wax Center, Inc. 42 EWCZ	21.26%	Oct. 5, 2024	USD 6.70	-0.74%	United States
43	Danaher Corporation 43 DHR	20.92%	Dec. 31, 2024	USD 214.26	-3.81%	United States
44	American Shared Hospital Services 44 AMS	20.82%	Sept. 30, 2024	USD 3.15	2.27%	United States
45	West Pharmaceutical Services, Inc. 45 WST	20.63%	Sept. 30, 2024	USD 337.03	-1.32%	United States
46	Zimmer Biomet Holdings, Inc. 46 ZBH	20.22%	Sept. 30, 2024	USD 108.16	-1.21%	United States
47	Bio-Techne Corporation 47 TECH	20.19%	Sept. 30, 2024	USD 72.05	-2.04%	United States
48	Fortive Corporation 48 FTV	20.12%	Sept. 27, 2024	USD 80.24	-1.34%	United States
49	Medpace Holdings, Inc. 49 MEDP	20.06%	Sept. 30, 2024	USD 343.38	-1.65%	United States
50	Insulet Corporation 50 PODD	19.35%	Sept. 30, 2024	USD 278.90	0.19%	United States

1 2 3 4 … 10

Frequently Asked Questions

Which Healthcare company in United States has the highest EBIT Margin ?

The Healthcare company in United States with the highest EBIT Margin is Inhibrx Biosciences, Inc. (NasdaqGS: INBX) at 95,369.20%.
Which Healthcare company in United States has the lowest EBIT Margin ?

The Healthcare company in United States with the lowest EBIT Margin is Inhibikase Therapeutics, Inc. (NasdaqCM: IKT) at -2,006,393,700.00%.

What are the top 10 Healthcare companies in United States by EBIT Margin ?

The top 10 Healthcare companies in United States by EBIT Margin are Inhibrx Biosciences, Inc., Maravai LifeSciences Holdings, Inc., Royalty Pharma plc, SIGA Technologies, Inc., United Therapeutics Corporation, Halozyme Therapeutics, Inc., Protagonist Therapeutics, Inc., Lantheus Holdings, Inc., Doximity, Inc. and Catalyst Pharmaceuticals, Inc..
What are the bottom 10 Healthcare companies in United States by EBIT Margin ?

The bottom 10 Healthcare companies in United States by EBIT Margin are Inhibikase Therapeutics, Inc., Immix Biopharma, Inc., Bullfrog AI Holdings, Inc. Common Stock, Benitec Biopharma Inc., Altimmune, Inc., Greenwich LifeSciences, Inc., Acelyrin, Inc., Allogene Therapeutics, Inc., INmune Bio, Inc. and 89bio, Inc..

Frequently Asked Questions

Don’t Miss A Beat